Lupus Pipeline Could See Momentum Following Two New US Approvals

Lupus Therapeutics Sees Improved Outlook For Challenging Area Of Drug Development

 
• By Jessica Merrill

Albert Roy, executive director of the clinical research arm of the Lupus Research Alliance, talked to Scrip about the outlook for lupus drug development.

Purple ribbon
Lupus Therapeutics hopes to see advances in drug development for SLE And LN • Source: Shutterstock

More from Immunological

More from Therapy Areas